The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics and growth rate of lung metastases in patients with primary gastrointestinal malignancies: A retrospective cohort analysis.
 
Shohei Burns
No Relationships to Disclose
 
Maya Vella
No Relationships to Disclose
 
Alan Paciorek
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis; Unity Biotechnology
Travel, Accommodations, Expenses - Dendreon; Dendreon; Dendreon
 
Chloe Evelyn Atreya
Stock and Other Ownership Interests - Pionyr
Consulting or Advisory Role - Array BioPharma; Pionyr
Research Funding - Bristol-Myers Squibb; Genentech (Inst); Guardant Health; Merck; Novartis
Travel, Accommodations, Expenses - Roche
 
Eric Andrew Collisson
Stock and Other Ownership Interests - BloodQ; Clara Health; Guardant Health; Hint Health; Tatara Therapeutics
Consulting or Advisory Role - Merck
Research Funding - Ferro Oncology/Bridge Bio (Inst); Loxo/Bayer (Inst); Merck KGaA (Inst); Senti Biosciences (Inst)
 
Mary Uan-Sian Feng
Honoraria - Medivation/Astellas (I); Myriad Pharmaceuticals (I); Reflexion Medical
Consulting or Advisory Role - GenomeDx (I); Myriad Pharmaceuticals (I); NanoString Technologies (I); Varian Medical Systems
Speakers' Bureau - Medivation/Astellas (I)
Research Funding - Celgene (I); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for RadioType Dx, a biomarker test (I)
Travel, Accommodations, Expenses - GenomeDx (I)
 
Robin Kate Kelley
Consulting or Advisory Role - Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exact Sciences; Genentech/Roche; Gilead Sciences; Merck (Inst)
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exelixis (Inst); Lilly (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Partner Therapeutics (Inst); QED Therapeutics (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Margaret A. Tempero
Honoraria - Japan Pancreas Society
Consulting or Advisory Role - Abbvie; Advance Medical; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene (Inst); CPRIT; EcoR1 Capital; Eisai; Elicio Therapeutics; FibroGen (Inst); GlaxoSmithKline; Halozyme (Inst); Immunovia; Ipsen; Karyopharm Therapeutics; Merck; Pharmacyclics; Swedish Orphan Biovitrum
Research Funding - Celgene (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BIOPHARM; Bristol-Myers Squibb; CPRIT; Eisai; GlaxoSmithKline; Merck; Pharmacyclics; Pharmacyte Biotech; Tocagen
 
Katherine Van Loon
Speakers' Bureau - Amgen; Physicans' Education Resource
Research Funding - Celgene (Inst); Celgene (Inst)
 
Andrew H. Ko
Honoraria - Clinical Care Options; Dava Oncology; Elsevier; OncLive; PER; Pharmatecture; PlatformQ Health; Research to Practice; Xcenda
Consulting or Advisory Role - ERYTECH Pharma; Gilead Sciences; Gritstone Bio; Imugene; MORE Health; SynCoreBio
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst)